Publications by authors named "F Charlotte"

Claim this Profile
A
An Invisible Early Steatosis Phenotype Defined for a Large Population-Based Cohort.
Thierry Poynard, Olivier Deckmyn, Valentina Peta, Raluca Pais, Bernard Van Beers, Frederic Charlotte

Biomedicines· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombospondin-2 is a performant biomarker of at-risk MASH and advanced MASH fibrosis in a large multicentre European cohort.
Vlad Ratziu, Rambabu Surabattula, Elisabetta Bugianesi, Jörn M Schattenberg, Sudha Myneni, Frédéric Charlotte

Gut· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simple, Rapid, Reproducible and Biomarker-Validated Clinical Grading System for Murine Models of Xenogeneic Graft-Versus-Host Disease.
Allan Thiolat, Cécile Pivert, Romane Bariseel, Frédéric Charlotte, Christine Sedlik

Transplant Cell Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of an interleukin-2 partial agonist enhances regulatory T cell persistence and efficacy in mouse autoimmune models.
Janie Robert, Manon Feuillolay, María de Temple-Llavero, Reginald Florian Akossi, Vanessa Mhanna, Frédéric Charlotte

Nat Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three Neglected STARD Criteria Reduce the Uncertainty of the Liver Fibrosis Biomarker FibroTest-T2D in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
Thierry Poynard, Olivier Deckmyn, Raluca Pais, Judith Aron-Wisnewsky, Valentina Peta, Frederic Charlotte

Diagnostics (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis